비교리스트

 카트 문의
시장보고서
상품코드
1486843

세계의 안압계 시장 : 인사이트, 경쟁 환경 및 시장 예측(-2030년)

Tonometers - Market Insights, Competitive Landscape and Market Forecast-2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계 안압계 시장 규모는 2023년 3억 3,929만 달러에 달했습니다. 이 시장은 2024년부터 2030년까지 예측 기간 동안 6.06%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 5억 5,566만 달러에 달할 것으로 예상됩니다. 안압계 수요는 주로 녹내장, 고혈압, 개방각 녹내장, 포도막염, 각막 질환, 백내장 수술, 녹내장에 걸리기 쉬운 당뇨병 인구와 같은 안과 질환의 발생률 증가로 인해 증가하고 있습니다. 또한, 안압계 시장은 전 세계적으로 정확도 향상, 사용 편의성, 환자 편의성 등 다양한 기술 발전으로 인해 성장할 것으로 예상됩니다. 이는 2024년부터 2030년까지 예측 기간 동안 안압계 시장의 긍정적인 성장에 기여하는 주요 요인입니다.

녹내장 진단을 받은 유병자는 2022년 주요 7개국에서 약 7,045,443명으로 추정되며, 녹내장의 전체 부담은 2022년 주요 7개국에서 약 16,632,421명(유병자)에 달할 것으로 예상됩니다. 녹내장은 시신경 손상을 특징으로 하는 진행성 안질환으로 안압(IOP) 상승을 동반하는 경우가 많아 안압계를 통한 상태 모니터링 및 진단이 필요하기 때문에 이러한 데이터와 통계는 전 세계 안압계의 미래 전체 시장을 촉진할 것으로 보입니다.

유럽위원회(2023년)에 따르면, 2021년 유럽연합(EU)에서는 백내장 수술이 주류를 이루며 EU 국가 전체에서 432만 건의 백내장 수술이 이루어졌습니다고 합니다. 또한 이 자료에 따르면, 2021년 인구 10만 명당 백내장 수술 건수가 가장 높은 국가는 프랑스(인구 10만 명당 1,417건)였으며, 오스트리아(인구 10만 명당 1,340건)가 그 뒤를 이었습니다. 또한 국제실명예방기구(IAPB)의 2020년 조사에 따르면, 중등도에서 중증의 백내장을 앓고 있는 전 세계 인구는 83,475,182명인 것으로 나타났습니다. 안압계는 백내장 수술의 수술 전과 수술 후 평가에 사용되어 안압(IOP)의 변화를 평가하고 관리하기 때문에 이러한 데이터와 통계는 전 세계 안압계의 미래 전체 시장에 박차를 가할 것으로 예상됩니다.

이 보고서는 세계 안압계 시장을 조사했으며, 시장 개요와 함께 기기 유형별/이동성별/최종 사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.

목차

제1장 안압계 시장 보고서 서론

제2장 안압계 시장 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 안압계 시장의 주요 요인 분석

  • 안압계 시장 성장 촉진요인
  • 안압계 시장 성장 억제요인과 과제
  • 안압계 시장 기회

제6장 안압계 시장 : Porter의 Five Forces 분석

제7장 안압계 시장 평가

  • 기기 유형별
  • 모빌리티
  • 최종사용자별
  • 지역별

제8장 안압계 시장 기업과 제품 개요

  • Halma Plc
  • HAAG-STREIT AG
  • Topcon Corporation
  • NIDEK CO., LTD
  • Reichert, Inc.
  • Keeler.
  • OCULUS Optikgerate GmbH
  • Tomey USA
  • CANON MEDICAL SYSTEMS USA, Inc.
  • Kowa Company, Ltd.,
  • Reichert, Inc.
  • AMETEK, Inc.
  • NIDEK CO., Ltd.
  • Accutome Inc.
  • Keeler.
  • Itamar Medical Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co Ltd.
  • Millar
  • DAEYOMEDI
  • Alam Medical

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항과 문의

LSH 24.06.05

Tonometer Market By Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, And Others}, Indentation Tonometers, Non- Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End- User (Hospitals, Opthalmic Clinic, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to the rising prevelance of opthalmic disorders such as glaucoma, ocular hypertension, uveitis, corneal disorders, cataract surgery, and technological advancement across the globe.

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030. The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open-angle glaucoma, uveitis, corneal disorders, cataract surgery, and the diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the tonometer market during the forecast period from 2024-2030.

Tonometer Market Dynamics:

According, to the estimates of DelveInsight the total glaucoma diagnosed prevalent cases were estimated at nearly 7,045,443 cases in 2022 in the 7MM, however the overall burden of glaucoma has been estimated to be nearly 16,632,421 (Prevalent cases) in 2022 in the 7MM. Hence, these data and stats are accepted to fuel the overall future market of tonometers across the globe as glaucoma is a progressive eye disease characterized by damage to the optic nerve, often associated with elevated intraocular pressure (IOP) and requires a tonometer for monitoring and diagnosing the conditions.

According to the European Commission (2023), in 2021, the European Union saw cataract surgery as the predominant surgical procedure, with a significant 4.32 million operations performed across EU nations. Additionally, as per the same source France had the highest rate of cataract surgery per 100,000 population in 2021 estimating 1,417 per 100,000 population followed by Austria (1,340 PER 100,000 population). Furthermore, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe cataracts was 83,475,182. These data and stats are accepted to fuel the overall future market of tonometer across the globe as tonometers are used during pre-operative and post-operative assessment of cataract surgery to assess and manage the changes in Intraocular pressure (IOP).

Furthermore, tonometers can be used as part of the overall assessment of diabetic eye disease and its complications. Additionally, as per the study conducted by the International Agency for the Prevention of Blindness (IAPB) in 2020, the global population affected by moderate to severe diabetic retinopathy was 3,278,034. Diabetic retinopathy is a complication of diabetes affecting the eyes and needs regular eye checkups including IOP measurements. Hence, the prevalence and incidence rates of ocular diseases such as glaucoma, cataract surgery, and diabetes retinopathy highlight the future significant market growth of tonometer.

Further, the continuous advancements in tonometry technology are driving the overall market of tonometers. In November 2022, NIDEK has introduced the NT-1p non-contact Tono/Pachymeter, an innovative device designed to automate both reliable non-contact tonometry and pachymetry. This advanced technology automatically detects the position of the eyes, initiating measurements without the need for manual button presses. This streamlined approach enhances efficiency and user experience, making the device particularly convenient for eye care professionals conducting intraocular pressure and corneal thickness assessments. Additionally, the growing awareness about the importance of regular eye check-ups and early detection of eye diseases is also contributing to fueling the current demand for tonometers.

However, the risk of infection with contact tonometers and lack of accuracy in non-contact tonometers during checkups may hinder the market demand for tonometers.

Tonometer Market Segment Analysis:

Tonometer Market by Device Types (Applanation {Goldman Tonometer, Perkins Applanation Tonometer, and Others}), Indentation Tonometers, Non-Contact Tonometer, Rebound Tonometer, Dynamic Contour Tonometer), Portability (Desktop Tonometer, Hand-Held Tonometer), End-User (Hospitals, Ophthalmic Clinic, And Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the tonometer market, the applanation tonometer category is estimated to have a significant revenue share in the tonometer market in 2023. This can be attributed to the various advantages and applications provided by the applanation tonometer. These devices are used to measure the intraocular pressure (IOP) by flattening a small area of the cornea and are considered one of the most accurate methods of measuring IOP. Applanation tonometers with non-contact options offer similar accuracy to contact tonometers. Some applanation tonometers, such as the Goldman tonometer, can be used in a non-contact mode, reducing the risk of corneal abrasions or infections associated with contact methods. Besides this, the absence of the need for fluorescein dye instillation or tropical anesthesia during tonometer use simplifies the procedure and enhances safety. All these advanced features of applanation tonometer are promoting the growth of overall tonometers. Applanation tonometers provide a direct measurement of IOP by directly assessing the cornea's response to pressure. Thus resulting in a more objective and accurate measurement of intraocular pressure.

Hence, the applanation tonometer is regarded as the gold standard for measuring IOP, and it's user-friendly and relatively easy operation, requiring minimal training for healthcare professionals will contribute to the growth of the overall tonometer market during the forecast period.

North America Is Expected To Dominate The Overall Tonometer Market:

North America is expected to account for the highest proportion of the global tonometer market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement.

According to the data provided by the Centers for Disease Control and Prevention (CDC) (2023), in 2021, in the United States, among people with diabetes, the prevalence rate of diabetes retinopathy was lowest among people younger than age 25 at 13.0% and highest among the 65-79 age group at 28.4%. Thus tonometer can be used to monitor IOP regularly in diabetic patients to detect any potential changes in IOP that may indicate the presence of glaucoma alongside diabetic retinopathy.

According to the latest data provided by the Centers for Disease Control and Prevention (CDC) (2020), glaucoma affects approximately 3 million Americans and ranks as the second leading cause of blindness globally. As per the same source, the number of glaucoma patients is expected to rise to 6.3 million by 2050 in America. The open-angle glaucoma, the predominant form is characterized by elevated eye pressure, often occurring without early symptoms and leaving 50% of affected individuals unaware of their condition. As a result, these statistics and data are expected to fuel the future market of tonometer devices in North America as intraocular pressure (IOP) monitoring is important in ocular disease to assess and manage the changes in IOP.

Furthermore, recent strategic initiatives and various product approvals of tonometers are also aiding in driving the market growth of tonometer devices in the region. In March 2022, Icare attained 510(k) clearance from the FDA in the United States for their latest self-tonometer iteration, the iCare HOME2. This innovative device is designed to simplify the process of measuring patients' intraocular pressure (IOP) beyond regular clinic hours, aiming to aid in the management of glaucoma. Thus the new product approval with advanced technologies is driving the market growth of tonometer in North America.

Additionally, the increase in the rising awareness programs by government authorities are also facilitating the overall use of tonometers thus increasing the future market of tonometer in the United States. Several government authorities in America such as the National Eye Health Education Program (NEHEP), in coordination with the National Eye Institute (NEI) of the National Institutes of Health (NIH) promotes eye health awareness across the United States like Glaucoma Awareness Month. Thus, the increased eye care awareness programs are contributing to market growth of tonometer In North America.

Tonometer Market Key Players:

Some of the key market players operating in the Tonometer include Ziemer Ophthalmic Systems AG, Haag- streit, Topcon Corporation, NIDEK CO., LTD, Reichert, Inc., Keeler., OCULUS Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek CO., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, DAEYOMEDI, Alam Medical.

Recent Developmental Activities In The Tonometer Market:

  • In May 2023 marked the launch of the Tono-Vera(R) Tonometer by Reichert Technologies, a subsidiary of AMETEK, Inc. This handheld tonometer, equipped with the ActiView(TM) Positioning System, stands out for its ability to deliver fast and dependable measurements of intraocular pressure, reinforcing Reichert's reputation as a global leader in eye care diagnostic devices.

Key Takeaways From The Tonometer Market Report Study

  • Market size analysis for current Tonometer Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Tonometer market.
  • Various opportunities available for the other competitors in the Tonometer Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Tonometer market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Tonometer market growth in the coming future?

Target Audience Who Can Be Benefited From This Tonometer Market Report Study

  • Tonometer product providers
  • Research organizations and consulting companies
  • Cardiac Restoration Systems-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Tonometer
  • Various end-users who want to know more about the Tonometer Market and the latest technological developments in the Tonometer Market.

Frequently Asked Questions For The Tonometer Market:

1. What are Tonometer?

A tonometer is a medical device used to measure the intraocular pressure (IOP) within the eye. Intraocular pressure refers to the fluid pressure inside the eye, which is primarily determined by the balance between the production and drainage of aqueous humor, the clear fluid that fills the anterior chamber of the eye.

2. What is the market for Tonometer?

The global Tonometer market was valued at USD 339.29 million in 2023, growing at a CAGR of 6.06% during the forecast period from 2024 to 2030 to reach USD 505.66 million by 2030.

3. What are the drivers for the global Tonometer market?

The demand for tonometers is primarily being boosted by the growing incidence of ophthalmic disorders such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, and diabetic population who are more prone to glaucoma. Furthermore, the tonometer market is anticipated to grow on account of a large number of technological advancements such as improved accuracy, ease of use, and patient comfort across the globe. These are the major drivers that are responsible for contributing to the positive growth of the Tonometer market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Tonometer market?

Some of the key market players operating in the Tonometer included Halma Plc, Haag- streit, Topcon Corporation, Nidek Co., Ltd, Reichert, Inc., Keeler., Oculus Optikgerate GmbH, Tomey USA, Canon medical systems USA, Inc., Kowa Company, Ltd., Reichert, Inc., Ametek, Inc., Nidek Co., Ltd., Accutome Inc., Keeler., Itamar Medical Ltd., Shenzhen Mindray Bio-Medical Electronics Co Ltd., Millar, Daeyomedi, Alam Medical.

5. Which region has the highest share in the global Tonometer market?

North America is expected to account for the highest proportion of the tonometer Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from an ophthalmic disorder such as glaucoma, ocular hypertension, open angle glaucoma, uveitis, corneal disorders, cataract surgery, diabetic population who are more prone to glaucoma, and technological advancement in tonometers are some other major factors that are responsible in contributing to the positive growth of the tonometer market in North America.

Table of Contents

1. Tonometer Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Tonometer Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Tonometer Market Key Factors Analysis

  • 5.1. Tonometer Market Drivers
    • 5.1.1. Rising prevalence of ophthalmic disorders such as glaucoma and others
    • 5.1.2. Innovation in technology
    • 5.1.3. Increasing awareness and screening programs
  • 5.2. Tonometer Market Restraints and Challenges
    • 5.2.1. Risk of infection in contact tonometers.
    • 5.2.2. Lack of accuracy in non-contact tonometers.
  • 5.3. Tonometer Market Opportunities
    • 5.3.1. Ongoing advancements in tonometry technology.

6. Tonometer Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Tonometer Market Assessment

  • 7.1. By Device Type
    • 7.1.1. Applanation Tonometer
      • 7.1.1.1. Goldman Tonometer
      • 7.1.1.2. Perkins Applanation Tonometer
      • 7.1.1.3. Others
    • 7.1.2. Indentation Tonometers
    • 7.1.3. Non-Contact Tonometer
    • 7.1.4. Rebound Tonometer
    • 7.1.5. Dynamic Contour Tonometer
  • 7.2. By Mobility
    • 7.2.1. Desktop Tonometer
    • 7.2.2. Hand-Held Tonometer
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Tonometer Market Size in USD million (2021-2030)
      • 7.4.1.2. Canada Tonometer Market Size in USD million (2021-2030)
      • 7.4.1.3. Mexico Tonometer Market Size in USD million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Tonometer Market Size in USD million (2021-2030)
      • 7.4.2.2. Germany Tonometer Market Size in USD million (2021-2030)
      • 7.4.2.3. United Kingdom Tonometer Market Size in USD million (2021-2030)
      • 7.4.2.4. Italy Tonometer Market Size in USD million (2021-2030)
      • 7.4.2.5. Spain Tonometer Market Size in USD million (2021-2030)
      • 7.4.2.6. Rest of Europe Tonometer Market Size in USD million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Tonometer Market Size in USD million (2021-2030)
      • 7.4.3.2. Japan Tonometer Market Size in USD million (2021-2030)
      • 7.4.3.3. India Tonometer Market Size in USD million (2021-2030)
      • 7.4.3.4. Australia Tonometer Market Size in USD million (2021-2030)
      • 7.4.3.5. South Korea Tonometer Market Size in USD million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Tonometer Market Size in USD million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Tonometer Market Size in USD million (2021-2030)
      • 7.4.4.2. Africa Tonometer Market Size in USD million (2021-2030)
      • 7.4.4.3. South America Tonometer Market Size in USD million (2021-2030)

8. Tonometer Market Company and Product Profiles

  • 8.1. Halma Plc
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. HAAG-STREIT AG
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Topcon Corporation
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. NIDEK CO., LTD
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Reichert, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Keeler.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. OCULUS Optikgerate GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Tomey USA
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. CANON MEDICAL SYSTEMS USA, Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Kowa Company, Ltd.,
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Reichert, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. AMETEK, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. NIDEK CO., Ltd.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Accutome Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Keeler.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Itamar Medical Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Shenzhen Mindray Bio-Medical Electronics Co Ltd.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Millar
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. DAEYOMEDI
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Alam Medical
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제